260 related articles for article (PubMed ID: 28426273)
1. Preclinical development of BCG.HIVA
Mahant A; Saubi N; Eto Y; Guitart N; Gatell JM; Hanke T; Joseph J
Hum Vaccin Immunother; 2017 Aug; 13(8):1798-1810. PubMed ID: 28426273
[TBL] [Abstract][Full Text] [Related]
2. Pre-clinical development of BCG.HIVA(CAT), an antibiotic-free selection strain, for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCG.
Saubi N; Mbewe-Mvula A; Gea-Mallorqui E; Rosario M; Gatell JM; Hanke T; Joseph J
PLoS One; 2012; 7(8):e42559. PubMed ID: 22927933
[TBL] [Abstract][Full Text] [Related]
3. Engineering new mycobacterial vaccine design for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCG.
Saubi N; Gea-Mallorquí E; Ferrer P; Hurtado C; Sánchez-Úbeda S; Eto Y; Gatell JM; Hanke T; Joseph J
Mol Ther Methods Clin Dev; 2014; 1():14017. PubMed ID: 26015961
[TBL] [Abstract][Full Text] [Related]
4. Priming With Recombinant BCG Expressing Novel HIV-1 Conserved Mosaic Immunogens and Boosting With Recombinant ChAdOx1 Is Safe, Stable, and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice.
Kilpeläinen A; Saubi N; Guitart N; Moyo N; Wee EG; Ravi K; Hanke T; Joseph J
Front Immunol; 2019; 10():923. PubMed ID: 31156614
[TBL] [Abstract][Full Text] [Related]
5. Safety and immunogenicity of novel recombinant BCG and modified vaccinia virus Ankara vaccines in neonate rhesus macaques.
Rosario M; Fulkerson J; Soneji S; Parker J; Im EJ; Borthwick N; Bridgeman A; Bourne C; Joseph J; Sadoff JC; Hanke T
J Virol; 2010 Aug; 84(15):7815-21. PubMed ID: 20484495
[TBL] [Abstract][Full Text] [Related]
6. Optimizing HIV-1-specific CD8+ T-cell induction by recombinant BCG in prime-boost regimens with heterologous viral vectors.
Hopkins R; Bridgeman A; Bourne C; Mbewe-Mvula A; Sadoff JC; Both GW; Joseph J; Fulkerson J; Hanke T
Eur J Immunol; 2011 Dec; 41(12):3542-52. PubMed ID: 21932450
[TBL] [Abstract][Full Text] [Related]
7. Priming with a recombinant pantothenate auxotroph of Mycobacterium bovis BCG and boosting with MVA elicits HIV-1 Gag specific CD8+ T cells.
Chapman R; Shephard E; Stutz H; Douglass N; Sambandamurthy V; Garcia I; Ryffel B; Jacobs W; Williamson AL
PLoS One; 2012; 7(3):e32769. PubMed ID: 22479338
[TBL] [Abstract][Full Text] [Related]
8. MTBVAC-Based TB-HIV Vaccine Is Safe, Elicits HIV-T Cell Responses, and Protects against
Broset E; Saubi N; Guitart N; Aguilo N; Uranga S; Kilpeläinen A; Eto Y; Hanke T; Gonzalo-Asensio J; Martín C; Joseph-Munné J
Mol Ther Methods Clin Dev; 2019 Jun; 13():253-264. PubMed ID: 30859110
[TBL] [Abstract][Full Text] [Related]
9. Novel recombinant Mycobacterium bovis BCG, ovine atadenovirus, and modified vaccinia virus Ankara vaccines combine to induce robust human immunodeficiency virus-specific CD4 and CD8 T-cell responses in rhesus macaques.
Rosario M; Hopkins R; Fulkerson J; Borthwick N; Quigley MF; Joseph J; Douek DC; Greenaway HY; Venturi V; Gostick E; Price DA; Both GW; Sadoff JC; Hanke T
J Virol; 2010 Jun; 84(12):5898-908. PubMed ID: 20375158
[TBL] [Abstract][Full Text] [Related]
10. Recombinant BCG Expressing HTI Prime and Recombinant ChAdOx1 Boost Is Safe and Elicits HIV-1-Specific T-Cell Responses in BALB/c Mice.
Kilpeläinen A; Saubi N; Guitart N; Olvera A; Hanke T; Brander C; Joseph J
Vaccines (Basel); 2019 Aug; 7(3):. PubMed ID: 31382453
[TBL] [Abstract][Full Text] [Related]
11. Dual neonate vaccine platform against HIV-1 and M. tuberculosis.
Hopkins R; Bridgeman A; Joseph J; Gilbert SC; McShane H; Hanke T
PLoS One; 2011; 6(5):e20067. PubMed ID: 21603645
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 Subtype C Mosaic Gag Expressed by BCG and MVA Elicits Persistent Effector T Cell Responses in a Prime-Boost Regimen in Mice.
Jongwe TI; Chapman R; Douglass N; Chetty S; Chege G; Williamson AL
PLoS One; 2016; 11(7):e0159141. PubMed ID: 27427967
[TBL] [Abstract][Full Text] [Related]
13. Advances and challenges in recombinant Mycobacterium bovis BCG-based HIV vaccine development: lessons learned.
Kilpeläinen A; Maya-Hoyos M; Saubí N; Soto CY; Joseph Munne J
Expert Rev Vaccines; 2018 Nov; 17(11):1005-1020. PubMed ID: 30300040
[TBL] [Abstract][Full Text] [Related]
14. Newborn mice vaccination with BCG.HIVA²²² + MVA.HIVA enhances HIV-1-specific immune responses: influence of age and immunization routes.
Saubi N; Im EJ; Fernández-Lloris R; Gil O; Cardona PJ; Gatell JM; Hanke T; Joseph J
Clin Dev Immunol; 2011; 2011():516219. PubMed ID: 21603216
[TBL] [Abstract][Full Text] [Related]
15. Robust immunity to an auxotrophic Mycobacterium bovis BCG-VLP prime-boost HIV vaccine candidate in a nonhuman primate model.
Chege GK; Burgers WA; Stutz H; Meyers AE; Chapman R; Kiravu A; Bunjun R; Shephard EG; Jacobs WR; Rybicki EP; Williamson AL
J Virol; 2013 May; 87(9):5151-60. PubMed ID: 23449790
[TBL] [Abstract][Full Text] [Related]
16. Construction and immunogenicity in a prime-boost regimen of a Semliki Forest virus-vectored experimental HIV clade A vaccine.
Hanke T; Barnfield C; Wee EG; Ågren L; Samuel RV; Larke N; Liljeström P
J Gen Virol; 2003 Feb; 84(Pt 2):361-368. PubMed ID: 12560568
[TBL] [Abstract][Full Text] [Related]
17. Induction of multifunctional human immunodeficiency virus type 1 (HIV-1)-specific T cells capable of proliferation in healthy subjects by using a prime-boost regimen of DNA- and modified vaccinia virus Ankara-vectored vaccines expressing HIV-1 Gag coupled to CD8+ T-cell epitopes.
Goonetilleke N; Moore S; Dally L; Winstone N; Cebere I; Mahmoud A; Pinheiro S; Gillespie G; Brown D; Loach V; Roberts J; Guimaraes-Walker A; Hayes P; Loughran K; Smith C; De Bont J; Verlinde C; Vooijs D; Schmidt C; Boaz M; Gilmour J; Fast P; Dorrell L; Hanke T; McMichael AJ
J Virol; 2006 May; 80(10):4717-28. PubMed ID: 16641265
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of antimycobacterial Th1-cell responses by a Mycobacterium bovis BCG prime-protein boost vaccination strategy.
Lu M; Xia ZY; Bao L
Cell Immunol; 2013; 285(1-2):111-7. PubMed ID: 24177251
[TBL] [Abstract][Full Text] [Related]
19. Vaccine platform for prevention of tuberculosis and mother-to-child transmission of human immunodeficiency virus type 1 through breastfeeding.
Im EJ; Saubi N; Virgili G; Sander C; Teoh D; Gatell JM; McShane H; Joseph J; Hanke T
J Virol; 2007 Sep; 81(17):9408-18. PubMed ID: 17596303
[TBL] [Abstract][Full Text] [Related]
20. Development of a Live Recombinant BCG Expressing Human Immunodeficiency Virus Type 1 (HIV-1) Gag Using a pMyong2 Vector System: Potential Use As a Novel HIV-1 Vaccine.
Kim BJ; Kim BR; Kook YH; Kim BJ
Front Immunol; 2018; 9():643. PubMed ID: 29636755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
